david braun, md, phd, considers the evolving treatment landscape of 1st line ccrcc
Published 3 years ago • 30 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
2:06
david braun, md, phd, shares how the treatment of ccrcc in the refractory setting is changing
-
3:01
david a. braun, md, phd, discusses the preliminary analysis of belzutifan cabozantinib in ccrcc
-
2:32
david a. braun, md, phd, regarding the follow-up trial investigating mk-6482 in ccrcc
-
1:28
dr. braun on evolution of immunotherapy in advanced renal cell carcinoma
-
2:18
david braun, md, phd, offers opinion on the role of hif-2α inhibitors in ccrcc
-
1:18
braun, immunoupdated
-
2:28
david braun, md on kidney cancer
-
2:21
kidney cancer and immune system dysfunction
-
0:50
the hospital’s role in tumor testing
-
2:01
meet radiation oncologist elizabeth bloom, m.d.
-
1:07
meet the doc: robert nadler, md, facs
-
1:42
elizabeth zheng, md – columbiadoctors transplant hepatologist
-
2:04
#kcrs20 "pushing the field forward" - dr. david braun, dfci
-
1:11
meet nephrologist aldo peixoto, md
-
1:21
dr. powell on msi and dmmr as potential biomarkers in endometrial cancer
-
![renal cancer case [#davincicases renal 7 - pathology case 2]](https://i.ytimg.com/vi/PTl-ki7w8cY/mqdefault.jpg)
11:00
renal cancer case [#davincicases renal 7 - pathology case 2]
-
19:24
implementing monoclonal antibodies for treatment and prevention in rls - david h. brown ripin
-
24:09
polycystic kidney and liver diseases (pkd and pld)
-
0:55
kidney cancer, hematology/oncology clinic, baton rouge, la